HLTH 2022: Neurotrack’s CEO Stresses Need For Three-Minute Digital Test To Detect Cognitive Decline Early
Executive Summary
Neurotrack hopes to bring its three-minute digital cognitive assessment tool into primary care offices as part of the Medicare Annual Wellness visit.
You may also be interested in...
Neurotrack Rethinks ‘Cognitive Health Program’ Website Following Ad Claims Challenge
Neurotrack Technologies revises website “to ensure that its communications better align with its evidence-backed offerings” following a National Advertising Division review of an advertising challenge by Posit Science.
Neurotrack Rethinks ‘Cognitive Health Program’ Website Following Ad Claims Challenge
Neurotrack Technologies revises website “to ensure that its communications better align with its evidence-backed offerings” following a National Advertising Division review of an advertising challenge by Posit Science.
NWW: Studies Back Nevro Pain Treatment, FTC Blesses Resonetics Nitinol Deal, Genetic Test Identifies Best RDN Patients
This week, studies supported Nevro’s spinal cord stimulation therapy and a VRx system that helps reduce pain; the American Medical Association found inconsistent insurance coverage of digital therapeutics; and Geneticure announced a cheek-swab test to identify which patients are most likely to benefit from renal denervation.